Home > National Drug Code (NDC) > Carisoprodol, Aspirin and Codeine Phosphate

Carisoprodol, Aspirin and Codeine Phosphate - 0185-0749-10 - (Carisoprodol, Aspirin and Codeine Phosphate)

Alphabetical Index


Drug Information of Carisoprodol, Aspirin and Codeine Phosphate

Product NDC: 0185-0749
Proprietary Name: Carisoprodol, Aspirin and Codeine Phosphate
Non Proprietary Name: Carisoprodol, Aspirin and Codeine Phosphate
Active Ingredient(s): 325; 200; 16    mg/1; mg/1; mg/1 & nbsp;   Carisoprodol, Aspirin and Codeine Phosphate
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carisoprodol, Aspirin and Codeine Phosphate

Product NDC: 0185-0749
Labeler Name: Eon Labs, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA040118
Marketing Category: ANDA
Start Marketing Date: 19960416

Package Information of Carisoprodol, Aspirin and Codeine Phosphate

Package NDC: 0185-0749-10
Package Description: 1000 TABLET in 1 BOTTLE (0185-0749-10)

NDC Information of Carisoprodol, Aspirin and Codeine Phosphate

NDC Code 0185-0749-10
Proprietary Name Carisoprodol, Aspirin and Codeine Phosphate
Package Description 1000 TABLET in 1 BOTTLE (0185-0749-10)
Product NDC 0185-0749
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carisoprodol, Aspirin and Codeine Phosphate
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19960416
Marketing Category Name ANDA
Labeler Name Eon Labs, Inc.
Substance Name ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
Strength Number 325; 200; 16
Strength Unit mg/1; mg/1; mg/1
Pharmaceutical Classes Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of Carisoprodol, Aspirin and Codeine Phosphate


General Information